agilon health (NYSE:AGL) Trading Down 5%

agilon health, inc. (NYSE:AGL)’s stock price was down 5% on Wednesday . The stock traded as low as $5.29 and last traded at $5.30. Approximately 667,166 shares traded hands during mid-day trading, a decline of 87% from the average daily volume of 5,081,688 shares. The stock had previously closed at $5.58.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. Benchmark reiterated a “buy” rating and issued a $9.00 target price on shares of agilon health in a report on Thursday, August 8th. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a report on Friday, August 9th. Citigroup started coverage on shares of agilon health in a report on Monday, April 22nd. They issued a “neutral” rating and a $6.00 target price on the stock. Evercore ISI lifted their price target on agilon health from $5.50 to $7.00 and gave the company an “in-line” rating in a research note on Tuesday, July 9th. Finally, Robert W. Baird began coverage on agilon health in a research note on Thursday, May 30th. They issued a “neutral” rating and a $6.00 price objective for the company. One research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, agilon health currently has a consensus rating of “Hold” and a consensus target price of $8.57.

agilon health Stock Performance

The company has a market cap of $2.11 billion, a P/E ratio of -7.51 and a beta of 0.60. The business has a 50 day moving average price of $6.48 and a two-hundred day moving average price of $5.98. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.33 and a current ratio of 1.33.

agilon health (NYSE:AGL) last issued its earnings results on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07). The company had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.56 billion. agilon health had a negative net margin of 5.67% and a negative return on equity of 26.15%. The firm’s revenue for the quarter was up 38.7% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.04) earnings per share. On average, sell-side analysts anticipate that agilon health, inc. will post -0.34 earnings per share for the current year.

Hedge Funds Weigh In On agilon health

A number of institutional investors have recently bought and sold shares of the stock. Raymond James & Associates bought a new position in shares of agilon health in the 4th quarter worth about $184,000. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of agilon health by 13.2% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 54,590 shares of the company’s stock valued at $685,000 after purchasing an additional 6,384 shares in the last quarter. Institute for Wealth Management LLC. purchased a new position in shares of agilon health during the fourth quarter valued at approximately $245,000. Duality Advisers LP bought a new stake in shares of agilon health in the 4th quarter worth approximately $192,000. Finally, State of New Jersey Common Pension Fund D grew its stake in shares of agilon health by 16.9% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 220,874 shares of the company’s stock worth $2,772,000 after buying an additional 31,986 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.